Humana Inc. (NYSE:HUM) Short Interest Down 14.6% in July

Humana Inc. (NYSE:HUM) was the recipient of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 2,570,000 shares, a decrease of 14.6% from the June 30th total of 3,010,000 shares. Approximately 2.1% of the company’s stock are short sold. Based on an average daily trading volume, of 1,460,000 shares, the short-interest ratio is presently 1.8 days.

Humana Price Performance

Shares of HUM traded down $42.91 during mid-day trading on Wednesday, reaching $361.61. 4,286,016 shares of the company’s stock were exchanged, compared to its average volume of 1,751,912. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. Humana has a 52-week low of $298.61 and a 52-week high of $530.54. The company has a market cap of $43.57 billion, a price-to-earnings ratio of 22.52, a PEG ratio of 2.27 and a beta of 0.51. The company has a 50-day simple moving average of $367.48 and a two-hundred day simple moving average of $347.60.

Institutional Trading of Humana

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Norges Bank purchased a new stake in shares of Humana in the fourth quarter valued at $676,800,000. Sanders Capital LLC acquired a new position in shares of Humana during the 4th quarter valued at about $489,300,000. Ontario Teachers Pension Plan Board lifted its holdings in shares of Humana by 11,647.2% during the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock worth $367,342,000 after acquiring an additional 1,050,459 shares during the period. Dimensional Fund Advisors LP grew its holdings in Humana by 0.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 984,618 shares of the insurance provider’s stock valued at $450,749,000 after purchasing an additional 8,164 shares during the period. Finally, Janus Henderson Group PLC increased its position in Humana by 47.4% during the first quarter. Janus Henderson Group PLC now owns 975,097 shares of the insurance provider’s stock worth $338,026,000 after purchasing an additional 313,530 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HUM has been the subject of several recent analyst reports. Truist Financial lifted their price objective on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. UBS Group cut their target price on Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Morgan Stanley started coverage on shares of Humana in a research note on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target on the stock. Baird R W upgraded shares of Humana to a “hold” rating in a research report on Thursday, May 30th. Finally, TD Cowen increased their target price on shares of Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. Fourteen analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $402.60.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.